{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:04:11Z","timestamp":1784822651514,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Matching survival of a donor kidney with that of the recipient (longevity matching), is used in some kidney allocation systems to maximize graft-life years. It is not part of the allocation algorithm for Australia. Given the growing evidence of survival benefit due to longevity matching based allocation algorithms, development of a similar kidney allocation system for Australia is currently underway. The aim of this research is to estimate the impact that changes to costs and health outcomes arising from \u2018longevity matching\u2019 on the Australian healthcare system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A decision analytic model to estimate cost-effectiveness was developed using a Markov process. Four plausible competing allocation options were compared to the current kidney allocation practice. Models were simulated in one-year\u2009cycles for a 20-year time horizon, with transitions through distinct health states relevant to the kidney recipient. Willingness to pay was considered as AUD 28000.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Base case analysis indicated that allocating the worst 20% of Kidney Donor Risk Index (KDRI) donor kidneys to the worst 20% of estimated post-transplant survival (EPTS) recipients (option 2) and allocating the oldest 25% of donor kidneys to the oldest 25% of recipients are both cost saving and more effective compared to the current Australian allocation practice.<\/jats:p>\n                    <jats:p>Option 2, returned the lowest costs, greatest health benefits and largest gain to net monetary benefits (NMB). Allocating the best 20% of KDRI donor kidneys to the best 20% of EPTS recipients had the lowest expected incremental NMB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Of the four longevity-based kidney allocation practices considered, transplanting the lowest quality kidneys to the worst kidney recipients (option 2), was estimated to return the best value for money for the Australian health system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05736-y","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T08:02:59Z","timestamp":1602230579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-2046","authenticated-orcid":false,"given":"Sameera","family":"Senanayake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-3267","authenticated-orcid":false,"given":"Nicholas","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4342-5300","authenticated-orcid":false,"given":"Helen","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-9353","authenticated-orcid":false,"given":"Keshwar","family":"Baboolal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-0374","authenticated-orcid":false,"given":"Adrian","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Sypek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5650-154X","authenticated-orcid":false,"given":"Sanjeewa","family":"Kularatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"12","key":"5736_CR1","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/01.tp.0000250715.32241.8a","volume":"82","author":"JS Gill","year":"2006","unstructured":"Gill JS, Gill J, Rose C, Zalunardo N, Landsberg D. The older living kidney donor: part of the solution to the organ shortage. Transplantation. 2006;82(12):1662\u20136.","journal-title":"Transplantation"},{"key":"5736_CR2","unstructured":"National Kidney Foundation. Organ donation and transplantation statistics: National Kidney Foundation; 2019 [cited 2019 October 23]. Available from: https:\/\/www.kidney.org\/news\/newsroom\/factsheets\/Organ-Donation-and-Transplantation-Stats."},{"key":"5736_CR3","unstructured":"NHS Blood and Transplant. Kidney acticity United Kingdom: NHS Blood and Transplant; 2020 [cited 2020 July 29]. Available from: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/19192\/section-5-kidney-activity.pdf."},{"key":"5736_CR4","unstructured":"Australian Government OaTA. Facts and statistics Australia: Australian Government, Organ and Tissue Authority; 2019 [cited 2020 July 29]. Available from: https:\/\/donatelife.gov.au\/about-donation\/frequently-asked-questions\/facts-and-statistics."},{"key":"5736_CR5","unstructured":"Global Observatory on Donation and Transplantation. Global data: World Health Organization (WHO) and the Spanish Transplant Organization; 2020 [cited 2020 July 29]. Available from: http:\/\/www.transplant-observatory.org\/summary\/."},{"issue":"4","key":"5736_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0955-470X(97)80038-9","volume":"11","author":"T Gutmann","year":"1997","unstructured":"Gutmann T, Land W. The ethics of organ allocation: the state of debate. Transplant Rev. 1997;11(4):191\u2013207.","journal-title":"Transplant Rev"},{"key":"5736_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fpubh.2017.00291","volume":"5","author":"N Rancic","year":"2017","unstructured":"Rancic N, Vavic N, Obrencevic K, Pilipovic F, Dragojevic-Simic V. Tacrolimus Utilization and expenditure in serbia. Front Publ Health. 2017;5:291.","journal-title":"Front Publ Health"},{"issue":"7","key":"5736_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/j.1600-6143.2005.00923.x","volume":"5","author":"HU Meier-Kriesche","year":"2005","unstructured":"Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B. Kidneys from deceased donors: maximizing the value of a scarce resource. Am J Transplant. 2005;5(7):1725\u201330.","journal-title":"Am J Transplant"},{"issue":"6","key":"5736_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/nep.13548","volume":"24","author":"D Lee","year":"2019","unstructured":"Lee D, Kanellis J, Mulley WR. Allocation of deceased donor kidneys: a review of international practices. Nephrology. 2019;24(6):591\u20138.","journal-title":"Nephrology"},{"issue":"8","key":"5736_CR10","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/j.1600-6143.2012.04141.x","volume":"12","author":"LF Ross","year":"2012","unstructured":"Ross LF, Parker W, Veatch RM, Gentry SE, Thistlethwaite J Jr. Equal opportunity supplemented by fair innings: equity and efficiency in allocating deceased donor kidneys. Am J Transpl. 2012;12(8):2115\u201324.","journal-title":"Am J Transpl"},{"issue":"8","key":"5736_CR11","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1681\/ASN.2013070784","volume":"25","author":"AK Israni","year":"2014","unstructured":"Israni AK, Salkowski N, Gustafson S, Snyder JJ, Friedewald JJ, Formica RN, et al. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol. 2014;25(8):1842\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"5736_CR12","volume-title":"Clinical Guidelines for Kidney Transplantation","author":"British Columbia Transplant","year":"2017","unstructured":"British Columbia Transplant. Clinical Guidelines for Kidney Transplantation 2017."},{"key":"5736_CR13","unstructured":"NHS Blood and Transplant. Kidney Transplantation: Deceased Donor Organ Allocation: NHS Blood and Transplant; 2019 [Available from: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/16915\/kidney-allocation-policy-pol186.pdf."},{"key":"5736_CR14","unstructured":"The Transplantation Society of Australia and New Zealand. Clinical Guidelines for Organ Transplantation from Deceased Donors. 2016. Cited: 11 Oct 2019. https:\/\/donatelife.gov.au\/sites\/default\/files\/TSANZ%20Clinical%20Guidelines%20for%20Organ%20Transplantation%20from%20Deceased%20Donors_Version%201.0_April%202016.pdf."},{"key":"5736_CR15","unstructured":"The Transplantation Society of Australia and New Zealand. Organ Transplantation from Deceased Donors: Background review Australia: The Transplantation Society of Australia and New Zealand; 2014 [Available from: https:\/\/www.tsanz.com.au\/standalonepages\/documents\/TSANZConsensusGuidelineLiteratureReview_DRAFT3.1.pdf."},{"issue":"7","key":"5736_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/imj.12797","volume":"45","author":"M Wyld","year":"2015","unstructured":"Wyld M, Lee C, Zhuo X, White S, Shaw J, Morton R, et al. Cost to government and society of chronic kidney disease stage 1\u20135: a national cohort study. Intern Med J. 2015;45(7):741\u20137.","journal-title":"Intern Med J"},{"issue":"1","key":"5736_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/kisup.2015.8","volume":"5","author":"SP McDonald","year":"2015","unstructured":"McDonald SP. Australia and New Zealand Dialysis and transplant registry. Kidney Int Suppl. 2015;5(1):39\u201344.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"5736_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-019-0198-z","volume":"18","author":"S Senanayake","year":"2020","unstructured":"Senanayake S, Graves N, Healy H, Baboolal K, Kularatna S. Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant;what pays? A systematic review. Cost Effect Resourc Alloc. 2020;18(1):1\u20133.","journal-title":"Cost Effect Resourc Alloc"},{"key":"5736_CR19","unstructured":"Medical Services Advisory Committee. Technical Guidelines for preparing assessment reports for the Medical Services Advisory Committee \u2013 Medical Service Type: Therapeutic (Version 2.0). Canberra: Australian Government, Department of Health; 2016."},{"key":"5736_CR20","volume-title":"The economic impact of end-stage kidney disease in Australia: projections to 2020","author":"A Cass","year":"2010","unstructured":"Cass A, Chadban S, Gallagher M, Howard K, Jones A, McDonald S, et al. The economic impact of end-stage kidney disease in Australia: projections to 2020. Melbourne: Kidney Health Australia; 2010."},{"key":"5736_CR21","volume-title":"40th annual ANZDATA report (2017)","author":"ANZDATA","year":"2018","unstructured":"ANZDATA. 40th annual ANZDATA report (2017). Australia: Australia and New Zealand Dialysis and Transplant Registry; 2018. http:\/\/www.anzdata.org.au\/v1\/report_2017.html."},{"issue":"9","key":"5736_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001307","volume":"9","author":"M Wyld","year":"2012","unstructured":"Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307.","journal-title":"PLoS Med"},{"issue":"8","key":"5736_CR23","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/ajt.12761","volume":"14","author":"PA Clayton","year":"2014","unstructured":"Clayton PA, McDonald SP, Snyder JJ, Salkowski N, Chadban SJ. External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(8):1922\u20136.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"12","key":"5736_CR24","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/ndt\/gfz090","volume":"34","author":"PA Clayton","year":"2019","unstructured":"Clayton PA, Dansie K, Sypek MP, White S, Chadban S, Kanellis J, Hughes P, Gulyani A, McDonald S. External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population. Nephrol Dial Transpl. 2019;34(12):2127\u201331.","journal-title":"Nephrol Dial Transpl"},{"issue":"24","key":"5736_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.21037\/atm.2016.08.45","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z. Parametric regression model for survival data: Weibull regression model as an example. Ann Transl Med. 2016;4(24):484\u201391.","journal-title":"Ann Transl Med"},{"issue":"8","key":"5736_CR26","first-page":"1005","volume":"5","author":"M Moosazadeh","year":"2014","unstructured":"Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N. Survival and predictors of death after successful treatment among smear positive tuberculosis: a cohort study. Int J Prev Med. 2014;5(8):1005\u201312.","journal-title":"Int J Prev Med"},{"key":"5736_CR27","volume-title":"Survival analysis using SAS: a practical guide: SAS institute","author":"PD Allison","year":"2010","unstructured":"Allison PD. Survival analysis using SAS: a practical guide: SAS institute; 2010."},{"issue":"1","key":"5736_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","volume":"25","author":"RL Fleurence","year":"2007","unstructured":"Fleurence RL, Hollenbeak CS. Rates and probabilities in economic Modelling. PharmacoEconomics. 2007;25(1):3\u20136.","journal-title":"PharmacoEconomics"},{"key":"5736_CR29","volume-title":"Evidence-based health economics: from effectiveness to efficiency in systematic review","author":"D Coyle","year":"2002","unstructured":"Coyle D, Lee KM. Evidence-based economic evaluation: how the use of different data sources can impact results. In: Donaldson C, Mugford M, Vale L, editors. Evidence-based health economics: from effectiveness to efficiency in systematic review. London: BMJ Books; 2002."},{"key":"5736_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.socscimed.2018.06.009","volume":"211","author":"L Huang","year":"2018","unstructured":"Huang L, Frijters P, Dalziel K, Clarke P. Life satisfaction, QALYs, and the monetary value of health. Soc Sci Med. 2018;211:131\u20136.","journal-title":"Soc Sci Med"},{"issue":"2","key":"5736_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40273-017-0585-2","volume":"36","author":"LC Edney","year":"2018","unstructured":"Edney LC, Afzali HH, Cheng TC, Karnon J. Estimating the reference incremental cost-effectiveness ratio for the Australian health system.Pharmacoeconomics. 2018;36(2):239\u201352.","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"5736_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1191\/0962280202sm306ra","volume":"11","author":"NJ Cooper","year":"2002","unstructured":"Cooper NJ, Sutton AJ, Abrams KR. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section. Stat Methods Med Res. 2002;11(6):491\u2013512.","journal-title":"Stat Methods Med Res"},{"issue":"21","key":"5736_CR33","first-page":"1746","volume":"103","author":"A Messori","year":"2017","unstructured":"Messori A, Trippoli S. The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit. Heart (British Cardiac Society). 2017;103(21):1746.","journal-title":"Heart (British Cardiac Society)"},{"issue":"2","key":"5736_CR34","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/cc7744","volume":"13","author":"KA Halton","year":"2009","unstructured":"Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care. 2009;13(2):R35.","journal-title":"Crit Care"},{"issue":"1","key":"5736_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trre.2016.10.002","volume":"31","author":"RN Formica Jr","year":"2017","unstructured":"Formica RN Jr. A critical assessment on kidney allocation systems. Transplant Rev. 2017;31(1):61\u20137.","journal-title":"Transplant Rev"},{"key":"5736_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ajt.14557","volume":"18","author":"A Hart","year":"2018","unstructured":"Hart A, Smith J, Skeans M, Gustafson S, Wilk A, Robinson A, et al. OPTN\/SRTR 2016 annual data report: kidney. Am J Transplant. 2018;18:18\u2013113.","journal-title":"Am J Transplant"},{"issue":"9","key":"5736_CR37","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1097\/TP.0000000000002144","volume":"102","author":"V Calisa","year":"2018","unstructured":"Calisa V, Craig JC, Howard K, Howell M, Alexander S, Chadban SJ, et al. Survival and quality of life impact of a risk-based allocation algorithm for deceased donor kidney transplantation. Transplantation. 2018;102(9):1530\u20137.","journal-title":"Transplantation"},{"issue":"4","key":"5736_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/TP.0000000000001057","volume":"100","author":"JM Smith","year":"2016","unstructured":"Smith JM, Schnitzler MA, Gustafson SK, Salkowski NJ, Snyder JJ, Kasiske BL, et al. Cost implications of new national allocation policy for deceased donor kidneys in the United States. Transplantation. 2016;100(4):879\u201385.","journal-title":"Transplantation"},{"issue":"4","key":"5736_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jamcollsurg.2016.12.009","volume":"224","author":"DJ Taber","year":"2017","unstructured":"Taber DJ, DuBay D, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK. Impact of the new kidney allocation system on perioperativeoutcomes and costs in kidney transplantation. J Am Coll Surg. 2017;224(4):585\u201392.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"5736_CR40","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1377\/hlthaff.2016.1625","volume":"36","author":"TA Melanson","year":"2017","unstructured":"Melanson TA, Hockenberry JM, Plantinga L, Basu M, Pastan S, Mohan S, Howard DH, Patzer RE. New kidney allocation system associated withincreased rates of transplants among black and Hispanic patients. Health Aff. 2017;36(6):1078\u201385.","journal-title":"Health Aff"},{"issue":"9","key":"5736_CR41","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/00007890-199811150-00006","volume":"66","author":"J Smits","year":"1998","unstructured":"Smits J, van Houwelingen HC, De Meester J, Persijn GG, Claas FH. Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation. 1998;66(9):1146\u201353.","journal-title":"Transplantation"},{"issue":"6","key":"5736_CR42","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2004121092","volume":"16","author":"GC Oniscu","year":"2005","unstructured":"Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol. 2005;16(6):1859\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5736_CR43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-6143.2007.02014.x","volume":"8","author":"U Frei","year":"2008","unstructured":"Frei U, Noeldeke J, Machold-Fabrizii VA, Arbogast H, Margreiter R, Fricke L, et al. Prospective age-matching in elderly kidney transplant recipients\u2014a 5-year analysis of the Eurotransplant senior program. Am J Transplant. 2008;8(1):50\u20137.","journal-title":"Am J Transplant"},{"issue":"4","key":"5736_CR44","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/TP.0000000000001405","volume":"101","author":"CL Jay","year":"2017","unstructured":"Jay CL, Washburn K, Dean PG, Helmick RA, Pugh JA, Stegall MD. Survival benefit in older patients associated with earlier transplant with high KDPI kidneys. Transplantation. 2017;101(4):867.","journal-title":"Transplantation"},{"issue":"10","key":"5736_CR45","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1111\/ajt.12830","volume":"14","author":"AB Massie","year":"2014","unstructured":"Massie AB, Luo X, Chow E, Alejo J, Desai NM, Segev D. Survival benefit of primary deceased donor transplantation with high-KDPI kidneys. Am J Transplant. 2014;14(10):2310\u20136.","journal-title":"Am J Transplant"},{"issue":"1","key":"5736_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.kint.2018.02.016","volume":"94","author":"S Mohan","year":"2018","unstructured":"Mohan S, Chiles MC, Patzer RE, Pastan SO, Husain SA, Carpenter DJ, Dube GK, Crew RJ, Ratner LE, Cohen DJ. Factors leading to the discard of deceased donor kidneys in the United States. Kidney Intl. 2018;94(1):187\u201398.","journal-title":"Kidney Intl"},{"key":"5736_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fpubh.2016.00189","volume":"4","author":"N Rancic","year":"2016","unstructured":"Rancic N, Dragojevic-Simic V, Vavic N, Kovacevic A, Segrt Z, Djordjevic N. Economic evaluation of pharmacogenetic tests in patients subjected to renal transplantation: a review of literature. Front Publ Health. 2016;4:189.","journal-title":"Front Publ Health"},{"key":"5736_CR48","doi-asserted-by":"crossref","unstructured":"Dziodzio T, Jara M, Hardt J, Weiss S, Ritschl PV, Denecke C, Biebl M, Gerlach U, Reinke P, Pratschke J, \u00d6llinger R. Effects of expanded allocation programmes and organ and recipient quality metrics on. Transpl Intl. 2019;32(10):1074\u201384.","DOI":"10.1111\/tri.13463"},{"issue":"2","key":"5736_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ajt.14018","volume":"17","author":"DA Axelrod","year":"2017","unstructured":"Axelrod DA, Schnitzler MA, Xiao H, Naik AS, Segev DL, Dharnidharka VR, Brennan DC, Lentine KL. The changing financial landscape of renal transplant practice: a national cohort analysis. Am J Transpl. 2017;17(2):377\u201389.","journal-title":"Am J Transpl"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05736-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T07:44:43Z","timestamp":1696837483000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05736-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5736"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05736-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-24828\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-24828\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-24828\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-24828\/v3","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been granted ethics approval by the Queensland University of Technology Human Research Ethics Committee (No: 1900000019). All patients consented to be enrolled in the ANZDATA registry and the need to consent for this study was waived. Administrative permission to access data was provided by the ANZDATA registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"931"}}